Back to search
FDAFDA · Food and drugs·Recall number D-1578-2014

PAXIL CR (Paroxetine HCL) Controlled-Release Tablets 25 mg, 30-count bottle, Rx only, Manufactured by GlaxoSmithKline, RTP, NC 27709, Manufactured for Apotex Corp., Weston, FL 33328, NDC 60505-3669-3

Published September 10, 2014 · Recall initiated: March 24, 2014

Summary

FDA records drug Class II recall D-1578-2014, published September 10, 2014 and initiated March 24, 2014. Recalling firm: Apotex Inc.; Status: Terminated; Lot: Lot # 2F004, Exp. 06/15. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Chemical Contamination: Product were manufactured with active pharmaceutical ingredient (API) batches contaminated with residual materials and solvents.

What to do

Voluntary: Firm initiated · Letter

Get an email if PAXIL has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
PAXIL
Manufacturer
Apotex Inc.
Distributor
Nationwide and Puerto Rico
UPC
0360505366835
Lot
Lot # 2F004, Exp. 06/15
Risk classification
Class II
Area (FDA)
drug
Country
Canada

Related recalls

Questions about this recall

Was PAXIL CR (Paroxetine HCL) Controlled-Release Tablets 25 mg, 30-count bottle, Rx only, Manufactured by GlaxoSmithKline, RTP, NC 27709, Manufactured for Apotex Corp., Weston, FL 33328, NDC 60505-3669-3 recalled?

Yes. FDA published recall D-1578-2014 on September 10, 2014. Reported hazard: Chemical Contamination: Product were manufactured with active pharmaceutical ingredient (API) batches contaminated with residual materials and solvents.

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: PAXIL. UPC: 0360505366835.